TUESDAY, Nov. 30, 2021 (HealthDay News) — Regeneron Pharmaceuticals said Tuesday that its antibody cocktail, which is used widely to treat COVID-19 patients, may be less effective against the Omicron variant. The company noted that prior analyses suggest that its monoclonal antibody cocktail, and similar drugs, could lose effectiveness againstContinue Reading

TUESDAY, Nov. 30, 2021 (HealthDay News) — U.S. cancer clinical trial participants have become more diverse in makeup, but certain groups remain underrepresented, a new study finds. It’s important to have a wide range of participants in clinical trials, to find out if treatments are safe and effective for peopleContinue Reading

TUESDAY, Nov. 30, 2021 (HealthDay News) — According to new research, people with psychiatric disorders often have to deal with another trouble: Higher rates of type 2 diabetes than the general population. “Increased prevalence of type 2 diabetes among individuals with a psychiatric disorder suggests that these conditions have aContinue Reading

MONDAY, Nov. 29, 2021 (HealthDay News) — Nearly 1 in 5 people with hypertension may be unintentionally taking a drug for another condition that causes their blood pressure to climb even higher, a new study suggests. Left untreated or undertreated, high blood pressure will increase your risk for heart attack,Continue Reading

MONDAY, Nov. 29, 2021 (HealthDay News) — A heart condition, myocarditis, has been found in a number of U.S. college athletes who have had COVID-19, a new study finds. Myocarditis has also been linked in some young people to the COVID vaccine. But the odds are far greater that thisContinue Reading